New York State Common Retirement Fund’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $22M | Hold |
174,774
| – | – | 0.03% | 414 |
|
2025
Q1 | $19.3M | Sell |
174,774
-3,000
| -2% | -$332K | 0.03% | 431 |
|
2024
Q4 | $24.3M | Sell |
177,774
-2,000
| -1% | -$273K | 0.03% | 374 |
|
2024
Q3 | $20.7M | Sell |
179,774
-28,633
| -14% | -$3.3M | 0.03% | 479 |
|
2024
Q2 | $28.7M | Buy |
208,407
+2,039
| +1% | +$281K | 0.04% | 363 |
|
2024
Q1 | $28.5M | Sell |
206,368
-8,028
| -4% | -$1.11M | 0.04% | 391 |
|
2023
Q4 | $28.2M | Sell |
214,396
-29,456
| -12% | -$3.88M | 0.04% | 395 |
|
2023
Q3 | $27.4M | Buy |
243,852
+30,539
| +14% | +$3.44M | 0.04% | 385 |
|
2023
Q2 | $20.1M | Buy |
213,313
+8,844
| +4% | +$834K | 0.03% | 559 |
|
2023
Q1 | $20.7M | Sell |
204,469
-25,770
| -11% | -$2.61M | 0.03% | 549 |
|
2022
Q4 | $27.5M | Sell |
230,239
-43,761
| -16% | -$5.23M | 0.04% | 424 |
|
2022
Q3 | $29.1M | Buy |
274,000
+23,213
| +9% | +$2.47M | 0.04% | 385 |
|
2022
Q2 | $24.4M | Buy |
250,787
+6,251
| +3% | +$609K | 0.03% | 466 |
|
2022
Q1 | $22.9M | Buy |
244,536
+31,479
| +15% | +$2.95M | 0.02% | 567 |
|
2021
Q4 | $18.1M | Buy |
213,057
+1,977
| +0.9% | +$168K | 0.02% | 714 |
|
2021
Q3 | $20.2M | Sell |
211,080
-39,506
| -16% | -$3.79M | 0.02% | 666 |
|
2021
Q2 | $24.4M | Sell |
250,586
-2,411
| -1% | -$235K | 0.03% | 596 |
|
2021
Q1 | $24.6M | Sell |
252,997
-10,309
| -4% | -$1M | 0.03% | 569 |
|
2020
Q4 | $25.2M | Buy |
263,306
+38,035
| +17% | +$3.65M | 0.03% | 550 |
|
2020
Q3 | $21.7M | Buy |
225,271
+43,563
| +24% | +$4.19M | 0.03% | 557 |
|
2020
Q2 | $22.2M | Sell |
181,708
-9,587
| -5% | -$1.17M | 0.03% | 544 |
|
2020
Q1 | $16.6M | Sell |
191,295
-755
| -0.4% | -$65.3K | 0.02% | 586 |
|
2019
Q4 | $20.6M | Sell |
192,050
-61,447
| -24% | -$6.6M | 0.02% | 637 |
|
2019
Q3 | $22.8M | Buy |
253,497
+1,290
| +0.5% | +$116K | 0.03% | 577 |
|
2019
Q2 | $21.3M | Buy |
252,207
+8,222
| +3% | +$694K | 0.03% | 628 |
|
2019
Q1 | $21.5M | Sell |
243,985
-17,929
| -7% | -$1.58M | 0.03% | 616 |
|
2018
Q4 | $18.7M | Sell |
261,914
-12,830
| -5% | -$916K | 0.03% | 614 |
|
2018
Q3 | $33.8M | Sell |
274,744
-55
| -0% | -$6.76K | 0.04% | 445 |
|
2018
Q2 | $27M | Sell |
274,799
-18,175
| -6% | -$1.79M | 0.03% | 541 |
|
2018
Q1 | $24.3M | Sell |
292,974
-1,010
| -0.3% | -$83.8K | 0.03% | 580 |
|
2017
Q4 | $22.8M | Buy |
293,984
+33,688
| +13% | +$2.61M | 0.03% | 620 |
|
2017
Q3 | $16M | Buy |
260,296
+4,895
| +2% | +$300K | 0.02% | 748 |
|
2017
Q2 | $11.7M | Buy |
255,401
+65,005
| +34% | +$2.99M | 0.02% | 897 |
|
2017
Q1 | $8.24M | Buy |
190,396
+4,996
| +3% | +$216K | 0.01% | 1031 |
|
2016
Q4 | $7.18M | Sell |
185,400
-21,695
| -10% | -$840K | 0.01% | 1086 |
|
2016
Q3 | $10.5M | Buy |
207,095
+14,450
| +8% | +$732K | 0.02% | 901 |
|
2016
Q2 | $8.76M | Buy |
192,645
+94,778
| +97% | +$4.31M | 0.01% | 993 |
|
2016
Q1 | $3.87M | Sell |
97,867
-6,559
| -6% | -$259K | 0.01% | 1315 |
|
2015
Q4 | $5.91M | Sell |
104,426
-549
| -0.5% | -$31.1K | 0.01% | 1144 |
|
2015
Q3 | $4.18M | Sell |
104,975
-2,723
| -3% | -$108K | 0.01% | 1288 |
|
2015
Q2 | $5.14M | Buy |
107,698
+101,238
| +1,567% | +$4.84M | 0.01% | 1336 |
|
2015
Q1 | $257K | Buy |
+6,460
| New | +$257K | ﹤0.01% | 2120 |
|